Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin and low-dose cytarabine in elderly AML
NCT00235560Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Jun 2005
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of sirolimus in acute myeloid leukemia (AML), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Complete Remission Rate. Started Jun 2005; status: completed.
02
Drugs
sirolimus
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00235560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235560.